Rapamycin has the ability to restore impaired autophagy by inhibiting the mammalian target of rapamycin (mTOR), leading to selective clearing of macrophages, increased cholesterol efflux, reduction of apoptotic cells in the plaques, and stabilization of atherosclerosis in ApoE-/- mice [5–7]. The gene discussed is APOE; the disease is atherosclerosis.